Ad is loading...
JTLRX
Price
$11.93
Change
-$0.01 (-0.08%)
Updated
Nov 14 closing price
PACAX
Price
$10.98
Change
-$0.02 (-0.18%)
Updated
Nov 14 closing price
Ad is loading...

JTLRX vs PACAX

Header iconJTLRX vs PACAX Comparison
Open Charts JTLRX vs PACAXBanner chart's image
JHancock Multimanager Lifestyle Cnsrv R5
Price$11.93
Change-$0.01 (-0.08%)
VolumeN/A
CapitalizationN/A
Putnam Dynamic Asset Allocation Cnsrv A
Price$10.98
Change-$0.02 (-0.18%)
VolumeN/A
CapitalizationN/A
JTLRX vs PACAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JTLRX vs. PACAX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JTLRX is a Hold and PACAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
JTLRX has more cash in the bank: 1.65B vs. PACAX (576M). JTLRX pays higher dividends than PACAX: JTLRX (3.88) vs PACAX (2.18). JTLRX was incepted earlier than PACAX: JTLRX (19 years) vs PACAX (31 years). PACAX is a more actively managed with annual turnover of: 456.00 vs. JTLRX (15.00). JTLRX (0) and PACAX (0) have matching initial minimum investment requirements. PACAX annual gain was more profitable for investors over the last year : 16.76 vs. JTLRX (12.02). PACAX return over 5 years is better than : 11.40 vs. JTLRX (8.72).
JTLRXPACAXJTLRX / PACAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years31 years-
Gain YTD6.41810.12363%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.65B576M287%
Annual Yield % from dividends3.882.18178%
Returns for 1 year12.0216.7672%
Returns for 3 years-3.55-2.74129%
Returns for 5 years8.7211.4076%
Returns for 10 years16.9915.39110%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GPGCX16.980.11
+0.65%
Grandeur Peak Global Contrarian Instl
JHLVX62.38N/A
N/A
JHancock Fundamental Large Cap Core C
FIUSX38.16N/A
N/A
Delaware Opportunity A
NSFEX11.43-0.04
-0.35%
Natixis Target Retirement 2025 N
ETNHX34.80-0.82
-2.30%
Eventide Healthcare & Life Sciences N